Type:

Oral immunotherapy shows positive results in adults with peanut allergy 27th May 2025

A new study, led by King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, has shown promising results, demonstrating that peanut oral immunotherapy (OIT) may be an effective treatment for adults with peanut allergies. The trial, known as

Read more
Get involved in research: help set the agenda for future research into food allergy in children 21st May 2025

Researchers at the University of Bristol and the James Lind Alliance invite you to take part in the second phase of a UK-wide survey to prioritise the most urgent unanswered questions about childhood food allergy. This is the second part of the

Read more
New study explores peanut allergy treatment for children with higher tolerance levels 20th February 2025

A recent study led by researchers at the Icahn School of Medicine at Mount Sinai, New York, has provided encouraging evidence that a supervised, gradual peanut ingestion protocol may help children with a high-threshold peanut allergy increase their tolerance to

Read more
Research opportunity: have you had a severe food allergy since childhood that requires use of an adrenaline auto-injector? 14th February 2025

The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their

Read more
Managing house dust mite allergy: treatment option now available on the NHS  12th February 2025

The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat

Read more
Needle-free nasal adrenaline treatment under review for approval in Canada and the UK 7th February 2025

ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis, ARS Pharmaceuticals has now filed for approval in

Read more
Peanut allergy patch shows promising long-term results in 3-year study 5th February 2025

A recent announcement from DBV Technologies revealed promising long-term results from its EPITOPE Study. Results from a 3-year study showed that the VIASKIN® Peanut patch can help children with peanut allergies become less sensitive to peanuts, reducing the risk of

Read more
Call for participants: help improve safety and support for those living with food allergies 4th February 2025

A group of health care professionals and patient representatives have created a Task Force on Food Allergen Ingestion Risk (‘FAIR’) within the European Academy of Allergy and Clinical Immunology (EAACI). This team is working to explore the challenges and needs

Read more
2024 allergy research & healthcare news roundup: key highlights and breakthroughs 30th January 2025

Living with allergies can sometimes feel isolating, especially when it seems like no one fully understands your struggles or when progress toward better solutions feels slow. However, it’s essential to look toward research to see the great strides being made

Read more